SCHEDULE 13D

Company

GT Biopharma, Inc.

Filed

December 31, 1996

Accession Number

0000950008-96-000385

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →